Arrowhead Pharmaceuticals (ARWR)'s 30-day implied volatility (IV30) was 47.8% at the close on October 21, 2026, down from 47.9% the day before, against a 52-week range of 42.8% to 88.1%. Its 20-day historical volatility was 46.1%.
Data as of October 21, 2026.